{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:35:58Z","timestamp":1792157758888,"version":"4.4.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022761","name":"Fakultn\u00ed Thomayerova nemocnice","doi-asserted-by":"publisher","award":["00064190"],"award-info":[{"award-number":["00064190"]}],"id":[{"id":"10.13039\/100022761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009553","name":"Agentura Pro Zdravotnick\u00fd V\u00fdzkum \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NU21J-03-00019"],"award-info":[{"award-number":["NU21J-03-00019"]}],"id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["EK-VP1261012020"],"award-info":[{"award-number":["EK-VP1261012020"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["EF16_013\/0001674"],"award-info":[{"award-number":["EF16_013\/0001674"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.modpat.2024.100689","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T15:54:44Z","timestamp":1734364484000},"page":"100689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Altered TP53, CDKN2A, ATM, EPHA7, POT1, CHEK1, GRIN2A, and EGFR Predict Shorter Survival in Penile Squamous Cell Carcinoma"],"prefix":"10.1016","volume":"38","author":[{"given":"Jan","family":"Hojn\u00fd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5649-4586","authenticated-orcid":false,"given":"Jan","family":"Hrudka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Prouzov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Kendall B\u00e1rt\u016f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Krkavcov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Dvo\u0159\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"Mich\u00e1lkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"\u010capka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolette","family":"Zavillov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radoslav","family":"Mat\u011bj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Waldauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.modpat.2024.100689_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-021-00246-5","article-title":"Penile cancer","volume":"7","author":"Thomas","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.modpat.2024.100689_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MOU.0000000000000581","article-title":"Penile cancer epidemiology and risk factors: a contemporary review","volume":"29","author":"Douglawi","year":"2019","journal-title":"Curr Opin Urol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100689_bib3","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.modpat.2024.100689_bib4","series-title":"WHO Classification of Tumours Editorial Board","first-page":"362","article-title":"Tumours of the penis and scrotum: introduction","volume":"vol 8","author":"Amin","year":"2022"},{"issue":"3","key":"10.1016\/j.modpat.2024.100689_bib5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.pathol.2023.10.010","article-title":"High tumour mutational burden is associated with strong PD-L1 expression, HPV negativity, and worse survival in penile squamous cell carcinoma: an analysis of 165 cases","volume":"56","author":"Hrudka","year":"2024","journal-title":"Pathology"},{"issue":"6","key":"10.1016\/j.modpat.2024.100689_bib6","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ejca.2012.10.029","article-title":"Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990","volume":"49","author":"Verhoeven","year":"2013","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.modpat.2024.100689_bib7","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/ijc.31194","article-title":"Trends in incidence, mortality and survival of penile squamous cell carcinoma in Norway 1956-2015","volume":"142","author":"Hansen","year":"2018","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.modpat.2024.100689_bib8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","article-title":"EAU guidelines on penile cancer: 2014 update","volume":"67","author":"Hakenberg","year":"2015","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100689_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.eururo.2023.04.018","article-title":"Management of lymph node-positive penile cancer: a systematic review","volume":"85","author":"Sachdeva","year":"2024","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.modpat.2024.100689_bib10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.pathol.2023.03.010","article-title":"Immune cell infiltration, tumour budding, and the p53 expression pattern are important predictors in penile squamous cell carcinoma: a retrospective study of 152 cases","volume":"55","author":"Hrudka","year":"2023","journal-title":"Pathology"},{"issue":"7","key":"10.1016\/j.modpat.2024.100689_bib11","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3889\/oamjms.2019.219","article-title":"P53 and survival rate in penile cancer","volume":"7","author":"Prapiska","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"issue":"3","key":"10.1016\/j.modpat.2024.100689_bib12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/jclinpath-2011-200429","article-title":"Expression of p53, p21 and cyclin D1 in penile cancer: p53 predicts poor prognosis","volume":"65","author":"Gunia","year":"2012","journal-title":"J\u00a0Clin Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100689_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00345-008-0275-y","article-title":"Molecular prognostic factors in penile cancer","volume":"27","author":"Muneer","year":"2009","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100689_bib14","first-page":"81","article-title":"p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy","volume":"168","author":"Lopes","year":"2002","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100689_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.clgc.2015.12.019","article-title":"Clinical significance of p53 and p16(ink4a) status in a contemporary North American penile carcinoma cohort","volume":"14","author":"Zargar-Shoshtari","year":"2016","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"10.1016\/j.modpat.2024.100689_bib16","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.clgc.2021.07.001","article-title":"p53 and p16ink4a as predictive and prognostic biomarkers for nodal metastasis and survival in a contemporary cohort of penile squamous cell carcinoma","volume":"19","author":"Mohanty","year":"2021","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"10.1016\/j.modpat.2024.100689_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ucl.2024.03.014","article-title":"Immune-based therapies for penile cancer","volume":"51","author":"Al Assaad","year":"2024","journal-title":"Urol Clin North Am"},{"issue":"11","key":"10.1016\/j.modpat.2024.100689_bib18","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.3390\/cancers16112086","article-title":"Therapeutic targets in advanced penile cancer: from bench to bedside","volume":"16","author":"Pagliaro","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.modpat.2024.100689_bib19","series-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2017"},{"issue":"4","key":"10.1016\/j.modpat.2024.100689_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jmoldx.2023.12.004","article-title":"Somatic genomic and transcriptomic characterization of primary ovarian serous borderline tumors and low-grade serous carcinomas","volume":"26","author":"Stru\u017einsk\u00e1","year":"2024","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.modpat.2024.100689_bib26","article-title":"OncoKB: a precision oncology knowledge base","volume":"2017","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"17","key":"10.1016\/j.modpat.2024.100689_bib29","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1158\/1078-0432.CCR-21-0327","article-title":"FDA approval summary: pembrolizumab for the treatment of tumor mutational burden-high solid tumors","volume":"27","author":"Marcus","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.modpat.2024.100689_bib30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/his.13429","article-title":"The World Health Organisation 2016 classification of penile carcinomas: a review and update from the International Society of Urological Pathology expert-driven recommendations","volume":"72","author":"Cubilla","year":"2018","journal-title":"Histopathology"},{"issue":"9","key":"10.1016\/j.modpat.2024.100689_bib31","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/modpathol.2017.46","article-title":"Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016","volume":"30","author":"Lugli","year":"2017","journal-title":"Mod Pathol"},{"issue":"24","key":"10.1016\/j.modpat.2024.100689_bib32","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","article-title":"Model predicting survival in stage I melanoma based on tumor progression","volume":"81","author":"Clark","year":"1989","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.modpat.2024.100689_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.11120\/msor.2001.01010023","article-title":"The R project in statistical computing","volume":"1","author":"Ripley","year":"2001","journal-title":"MSOR Connect"},{"key":"10.1016\/j.modpat.2024.100689_bib35","author":"Bender"},{"issue":"1","key":"10.1016\/j.modpat.2024.100689_bib36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/ijms23010251","article-title":"Pathogenesis of penile squamous cell carcinoma: molecular update and systematic review","volume":"23","author":"Ribera-Cortada","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.modpat.2024.100689_bib37","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/mc.23185","article-title":"Genomic profiling reveals the pivotal role of hrHPV driving copy number and gene expression alterations, including mRNA downregulation of TP53 and RB1 in penile cancer","volume":"59","author":"Macedo","year":"2020","journal-title":"Mol Carcinog"},{"issue":"5","key":"10.1016\/j.modpat.2024.100689_bib38","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/ijc.32373","article-title":"Mutational landscape of penile squamous cell carcinoma in a Chinese population","volume":"145","author":"Wang","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.modpat.2024.100689_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.596261","article-title":"Copy number analysis reveal genetic risks of penile cancer","volume":"10","author":"Yu","year":"2020","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.modpat.2024.100689_bib40","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/gcc.22274","article-title":"Identification of somatic gene mutations in penile squamous cell carcinoma","volume":"54","author":"Ferr\u00e1ndiz-Pulido","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"issue":"16","key":"10.1016\/j.modpat.2024.100689_bib41","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1158\/0008-5472.CAN-15-3134","article-title":"CSN1 somatic mutations in penile squamous cell carcinoma","volume":"76","author":"Feber","year":"2016","journal-title":"Cancer Res"},{"issue":"24","key":"10.1016\/j.modpat.2024.100689_bib42","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1158\/0008-5472.CAN-15-1004","article-title":"Genomic profiling of penile squamous cell carcinoma reveals new opportunities for targeted therapy","volume":"75","author":"McDaniel","year":"2015","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.modpat.2024.100689_bib43","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1158\/1078-0432.CCR-20-4004","article-title":"Whole-exome sequencing in penile squamous cell carcinoma uncovers novel prognostic categorization and drug targets similar to head and neck squamous cell carcinoma","volume":"27","author":"Chahoud","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.modpat.2024.100689_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100250","article-title":"Different mutational landscapes in human papillomavirus-induced and human papillomavirus-independent invasive penile squamous cell cancers","volume":"36","author":"Ermakov","year":"2023","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100689_bib45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00428-010-1007-4","article-title":"Alterations in the tumor suppressor gene p16(INK4A) are associated with aggressive behavior of penile carcinomas","volume":"458","author":"Poetsch","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.modpat.2024.100689_bib46","doi-asserted-by":"crossref","unstructured":"Elst L, Philips G, Vandermaesen K, et\u00a0al. Single-cell atlas of penile cancer reveals TP53 mutations as a driver of an aggressive phenotype, irrespective of human papillomavirus status, and provides clues for treatment personalization. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.038","DOI":"10.1016\/j.eururo.2024.03.038"},{"key":"10.1016\/j.modpat.2024.100689_bib47","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.eururo.2024.03.038","article-title":"Single-cell atlas of penile cancer reveals TP53 mutations as a driver of an aggressive phenotype, irrespective of human papillomavirus status, and provides clues for treatment personalization","volume":"86","author":"Hrudka","year":"2024","journal-title":"Eur Urol"},{"issue":"2-3","key":"10.1016\/j.modpat.2024.100689_bib49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000495251","article-title":"No evidence of microsatellite instability and loss of mismatch-repair-protein expression in squamous cell carcinoma of the penis","volume":"86","author":"Stoehr","year":"2019","journal-title":"Pathobiology"},{"issue":"17","key":"10.1016\/j.modpat.2024.100689_bib51","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1200\/JCO.20.02903","article-title":"Tipifarnib in head and neck squamous cell carcinoma with HRAS mutations","volume":"39","author":"Ho","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"24","key":"10.1016\/j.modpat.2024.100689_bib52","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.3390\/cancers14246024","article-title":"Prognostic significance of p16 and its relationship with human papillomavirus status in patients with penile squamous cell carcinoma: results of 5 years follow-up","volume":"14","author":"Chahoud","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.modpat.2024.100689_bib53","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.3390\/cells9122677","article-title":"NOTCH1 signaling in head and neck squamous cell carcinoma","volume":"9","author":"Shah","year":"2020","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.modpat.2024.100689_bib54","first-page":"1320","article-title":"FAT1 somatic mutations in head and neck carcinoma are associated with tumor progression and survival","volume":"39","author":"Lin","year":"2018","journal-title":"Carcinogenesis"},{"issue":"58","key":"10.1016\/j.modpat.2024.100689_bib55","doi-asserted-by":"crossref","first-page":"98887","DOI":"10.18632\/oncotarget.21946","article-title":"Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1","volume":"8","author":"Kang","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.modpat.2024.100689_bib56","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1007\/s11033-020-05571-8","article-title":"Critical role of EphA3 in cancer and current state of EphA3 drug therapeutics","volume":"47","author":"London","year":"2020","journal-title":"Mol Biol Rep"},{"issue":"1","key":"10.1016\/j.modpat.2024.100689_bib57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3816\/CLML.2011.n.006","article-title":"Copy number variations of EphA3 are associated with multiple types of hematologic malignancies","volume":"11","author":"Guan","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"10.1016\/j.modpat.2024.100689_bib58","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccr.2013.01.007","article-title":"EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme","volume":"23","author":"Day","year":"2013","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.modpat.2024.100689_bib59","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1016\/j.clgc.2016.07.028","article-title":"Loss of EphA3 protein expression is associated with advanced TNM stage in clear-cell renal cell carcinoma","volume":"15","author":"Wang","year":"2017","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"10.1016\/j.modpat.2024.100689_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1878-0261.12155","article-title":"Emerging functions of the EGFR in cancer","volume":"12","author":"Sigismund","year":"2018","journal-title":"Mol Oncol"},{"issue":"8","key":"10.1016\/j.modpat.2024.100689_bib61","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrc3309","article-title":"The ERBB network: at last, cancer therapy meets systems biology","volume":"12","author":"Yarden","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"10.1016\/j.modpat.2024.100689_bib62","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/jid.2014.190","article-title":"Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation","volume":"134","author":"Prickett","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.modpat.2024.100689_bib63","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fonc.2013.00333","article-title":"Evidence that GRIN2A mutations in melanoma correlate with decreased survival","volume":"3","author":"D\u2019mello","year":"2014","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100689_bib64","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00345-024-05188-7","article-title":"Real-world data on the prevalence of BRCA1\/2 and HRR gene mutations in patients with primary and metastatic castration resistant prostate cancer","volume":"42","author":"Hommerding","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.modpat.2024.100689_bib65","article-title":"DNA-damaging therapies in patients with prostate cancer and pathogenic alterations in homologous recombination repair genes","volume":"8","author":"Graham","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.modpat.2024.100689_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116781","article-title":"Progress of ATM inhibitors: opportunities and challenges","volume":"277","author":"Du","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"7","key":"10.1016\/j.modpat.2024.100689_bib67","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1007\/s12094-022-02783-1","article-title":"The role of EphA7 in different tumors","volume":"24","author":"Chen","year":"2022","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100689_bib68","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1267\/ahc.14054","article-title":"Low EphA7 expression correlated with lymph node metastasis and poor prognosis of patients with esophageal squamous cell carcinoma","volume":"48","author":"Bai","year":"2015","journal-title":"Acta Histochem Cytochem"},{"issue":"2","key":"10.1016\/j.modpat.2024.100689_bib69","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s12253-013-9692-3","article-title":"Ephrin receptor (Eph) -A1, -A2, -A4 and -A7 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival","volume":"20","author":"Theocharis","year":"2014","journal-title":"Pathol Oncol Res"},{"issue":"2","key":"10.1016\/j.modpat.2024.100689_bib70","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1159\/000430110","article-title":"Effect of EphA7 silencing on proliferation, invasion and apoptosis in human laryngeal cancer cell lines Hep-2 and AMC-HN-8","volume":"36","author":"Xiang","year":"2015","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"10.1016\/j.modpat.2024.100689_bib71","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1002\/jcb.29548","article-title":"Long noncoding RNA KCNQ1OT1 promotes proliferation, migration, and invasion in maxillary sinus squamous cell carcinoma by regulating miR-204\/EphA7 axis","volume":"121","author":"Sun","year":"2020","journal-title":"J\u00a0Cell Biochem"},{"issue":"4","key":"10.1016\/j.modpat.2024.100689_bib72","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a005439","article-title":"Functional genomic analysis identifies drug targetable pathways in invasive and metastatic cutaneous squamous cell carcinoma","volume":"6","author":"Anderson","year":"2020","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"21","key":"10.1016\/j.modpat.2024.100689_bib73","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.3390\/cancers14215278","article-title":"DNA repair mechanisms, protein interactions and therapeutic targeting of the MRN complex","volume":"14","author":"McCarthy-Leo","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.modpat.2024.100689_bib74","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3390\/cancers12030662","article-title":"Gene expression alterations and molecular analysis of CHEK1 in solid tumors","volume":"12","author":"Fadaka","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"22","key":"10.1016\/j.modpat.2024.100689_bib75","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","article-title":"Olaparib for metastatic castration-resistant prostate cancer","volume":"382","author":"de Bono","year":"2020","journal-title":"N\u00a0Engl J Med"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224002692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224002692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:59:52Z","timestamp":1762315192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395224002692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0893395224002692"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100689","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered TP53, CDKN2A, ATM, EPHA7, POT1, CHEK1, GRIN2A, and EGFR Predict Shorter Survival in Penile Squamous Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"100689"}}